Pharmaceutical companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 44 pharmaceutical companies in the United States ranked by one-year price change, at +387%, ahead of Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%). Figures as of 20 Nov 2026, 12:00 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Erasca+387%
- Median
- +22.1%
- Combined market value
- SEK 38.17T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +387% | SEK 51B | SEK 145.30 | 3.34% up | 387% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +302% | SEK 94.7B | SEK 997.60 | 3.77% down | 302% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +233% | SEK 67.6B | SEK 996.98 | 1.91% up | 233% up | ||
| 4 | VeradermicsMANE · Health Care | +230% | SEK 53.6B | SEK 1,271.03 | 0.38% down | 230% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +176% | SEK 41.2B | SEK 301.23 | 1.24% up | 176% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | +105% | SEK 48.8B | SEK 866.80 | 1.01% up | 105% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +103% | SEK 100.2B | SEK 662.95 | 1.88% down | 103% up | ||
| 8 | ViatrisVTRS · Health Care | +90.1% | SEK 232.9B | SEK 203.14 | 1.97% down | 90% up | ||
| 9 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | SEK 88.8B | SEK 3,176.82 | 1.87% up | 83% up | ||
| 10 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | SEK 46.1B | SEK 420.68 | 0.48% down | 82% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | SEK 76.2B | SEK 218.57 | 2.24% down | 79% up | ||
| 12 | Royalty PharmaRPRX · Health Care | +74.0% | SEK 397.9B | SEK 691.97 | 1.38% down | 74% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | SEK 82.7B | SEK 1,267.25 | 2.47% down | 45% up | ||
| 14 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | SEK 58.6B | SEK 2,931.99 | 3.94% down | 44% up | ||
| 15 | Travere TherapeuticsTVTX · Health Care | +39.2% | SEK 47.4B | SEK 493.54 | 3.86% down | 39% up | ||
| 16 | Merck & CoMRK · Health Care | +35.9% | SEK 3.35T | SEK 1,357.07 | 3.61% down | 36% up | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | SEK 63.7B | SEK 975.93 | 3.27% up | 35% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | +31.0% | SEK 6.57T | SEK 2,729.67 | 2.04% down | 31% up | ||
| 19 | Eli LillyLLY · Health Care | +27.5% | SEK 12.3T | SEK 13,805.93 | 2.29% down | 28% up | ||
| 20 | Bristol-Myers SquibbBMY · Health Care | +26.1% | SEK 1.22T | SEK 596.13 | 2.05% down | 26% up | ||
| 21 | Belite BioBLTE · Health Care | +25.3% | SEK 62.7B | SEK 1,543.14 | 3.33% down | 25% up | ||
| 22 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | SEK 976B | SEK 9,434.82 | 2.35% down | 22% up | ||
| 23 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | SEK 1.35T | SEK 5,320.18 | 2.94% down | 22% up | ||
| 24 | AbbVieABBV · Health Care | +20.0% | SEK 5.12T | SEK 2,897.25 | 0.86% down | 20% up | ||
| 25 | Elanco Animal HealthELAN · Health Care | +18.2% | SEK 134.3B | SEK 268.63 | 1.54% down | 18% up | ||
| 26 | United TherapeuticsUTHR · Health Care | +17.7% | SEK 243.3B | SEK 5,712.96 | 3.16% down | 18% up | ||
| 27 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | SEK 82.7B | SEK 1,193.48 | 1.88% down | 15% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | +14.8% | SEK 155.6B | SEK 798.85 | 0.22% up | 15% up | ||
| 29 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | SEK 121.6B | SEK 627.60 | 0.02% down | 12% up | ||
| 30 | PfizerPFE · Health Care | +9.98% | SEK 1.6T | SEK 281.41 | 1.85% down | 10% up | ||
| 31 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | SEK 63.1B | SEK 446.02 | 1.25% up | 8% up | ||
| 32 | Axsome TherapeuticsAXSM · Health Care | -9.21% | SEK 72.9B | SEK 1,386.40 | 1.25% up | 9% down | ||
| 33 | Corcept TherapeuticsCORT · Health Care | -15.9% | SEK 72.7B | SEK 663.97 | 4.15% down | 16% down | ||
| 34 | Abbott LaboratoriesABT · Health Care | -18.9% | SEK 1.84T | SEK 1,061.36 | 0.58% down | 19% down | ||
| 35 | CytokineticsCYTK · Health Care | -21.4% | SEK 73.2B | SEK 525.83 | 0.27% up | 21% down | ||
| 36 | Cogent BiosciencesCOGT · Health Care | -24.5% | SEK 49.3B | SEK 283.45 | 0.25% down | 25% down | ||
| 37 | PTC TherapeuticsPTCT · Health Care | -25.7% | SEK 49.8B | SEK 595.97 | 3.16% down | 26% down | ||
| 38 | InsmedINSM · Health Care | -27.3% | SEK 323.8B | SEK 1,476.11 | 20.58% up | 27% down | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | -27.6% | SEK 94.2B | SEK 4,053.94 | 0.34% down | 28% down | ||
| 40 | ZoetisZTS · Health Care | -33.8% | SEK 335.4B | SEK 825.52 | 5.59% down | 34% down | ||
| 41 | Summit TherapeuticsSMMT · Health Care | -34.7% | SEK 86.4B | SEK 108.01 | 0.67% up | 35% down | ||
| 42 | Legend BiotechLEGN · Health Care | -42.8% | SEK 31.9B | SEK 164.51 | 0.92% down | 43% down | ||
| 43 | Ionis PharmaceuticalsIONS · Health Care | -64.2% | SEK 46.3B | SEK 278.14 | 0.62% down | 64% down | ||
| 44 | Alnylam PharmaceuticalsALNY · Health Care | -66.1% | SEK 202.3B | SEK 1,510.45 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2181 SEK).
Questions and answers
Which pharmaceutical companies in the United States rank first by one-year price change?
Erasca (+387%), Spyre Therapeutics (+302%) and Oruka Therapeutics (+233%) are the top three of the 44 pharmaceutical companies in the United States ranked by one-year price change as of 20 Nov 2026, 12:00 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by one-year price change.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by one-year price change have a combined market value of SEK 38.17T as of 20 Nov 2026, 12:00 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies in the United States by one-year price change”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.